Wrong CMO/CDMO Fit
Technical capability, GMP maturity or strategic fit may be overestimated.
Executive Consulting Services
De-risk your next
outsourced manufacturing decision
CMC Compliance support for outsourced API & FDF manufacturing — helping pharma companies select, transfer and oversee external manufacturing partners with technical, GMP and regulatory confidence.
The Challenge
Outsourcing Creates Opportunity — and Risk
API and FDF external manufacturing can increase flexibility, reduce investment and accelerate execution. The risks must be actively managed.
Dossier vs Reality Gaps
Manufacturing changes may drift from approved CMC commitments.
Transfer Execution Failure
Poor readiness can trigger deviations, validation issues and delays.
Supply Disruption
Quality events or change delays can interrupt availability.
The product owner remains accountable for quality, regulatory compliance and supply continuity — even when manufacturing is outsourced.
Our Services
CMC Compliance Across the Outsourced Manufacturing Lifecycle
One integrated approach from partner selection to lifecycle control.
Before outsourcing
CMO/CDMO Scouting, Selection & Oversight
Right partner, right capabilities, right controls.
During transfer
Tech Transfer Support
Controlled transfer, reduced execution risk.
After approval / supply
Lifecycle Management Support
Compliant changes and sustained product control.
Manufacturing Scope
API and FDF Outsourced Manufacturing Support
Small molecule API manufacturing operations and FDF products across solid oral dosage forms and sterile / aseptic technologies.
- API manufacturing
- Tablets & capsules
- Injectables
- Inhalation products
Service Detail
Three Services, One Integrated Model
Before outsourcing
Selecting the right manufacturing partner before risk becomes cost
Objective: identify, assess, select and oversee CMOs/CDMOs based on technical capability, GMP maturity, CMC fit and long-term supply reliability.
01
Requirements Assessment
Dosage form, batch size, process complexity and commercial strategy alignment.
02
CMO/CDMO Scouting
Manufacturing, analytical, QMS and regulatory track record assessment.
03
Due Diligence
Site technical / commercial visit and confirmation of operational capabilities and quality system robustness.
04
Risk-Based Selection
Pre-selection of candidates, RFP/RFQ, benchmark exercise.
05
Oversight Model
Governance, KPIs, supply and technical agreements and on-going performance control.
Risk-Based Assessment Framework
A structured decision model that balances capability, compliance and execution risk.
Technical fit API/FDF technology, dosage form, scale and process complexity
GMP maturity QMS robustness, deviation/CAPA effectiveness and audit history
Regulatory track record Market experience, inspection outcomes and submission readiness
Analytical capability Method transfer, QC capacity and data integrity expectations
Supply reliability Capacity, redundancy, lead times and business continuity
CMO mindset Transparency, responsiveness, agreements and KPI discipline
Output: a CMC/GMP due diligence report, risk-based selection matrix and CMO oversight plan.
During transfer
Turning transfer complexity into controlled CMC execution
Objective: support the transfer of product and process knowledge between sites while keeping manufacturing, analytical controls, validation strategy and CMC documentation aligned.
01
Data gathering & evaluation
Data package assessment, process knowledge and gaps.
02
Transfer Strategy and Planning
Define scope, responsibilities, governance and define Tech Transfer Plan.
03
Process and analytical transfer
Analytical Method transfer and manufacturing documentation.
04
Validation Readiness
Transfer batches, PPQ and documentation support.
05
CMC Impact Assessment
Variation submission for dossier alignment.
Outcome: controlled transfer with fewer deviations, validation issues, timeline delays and regulatory inconsistencies.
After approval / supply
Keeping outsourced products compliant through change
Objective: support CMC lifecycle management for outsourced products, ensuring post-approval changes, site transfers, process improvements and regulatory commitments are managed efficiently.
01
Dossier vs Reality Check
Assess dossier alignment with current practice.
02
Compliance & Remediation Activities Proposal
CMC remediation plans for GAPS.
03
Implementation Follow up
04
Process Optimization and Cost Reduction
05
Sustained CMC Control
Product quality review support.
Who Is Behind Binding Partners
Senior CMC Expertise, Complementary Perspectives
Executive Perspective
Pablo Magnani
Founder & Principal Consultant
Chemical Engineer with 30+ years of experience in the pharmaceutical industry, spanning drug substance and drug product. Proven track record working across innovators, generics, and CDMOs —on both, the seller and customer sides— while effectively navigating diverse cultural and organizational environments.
Bringing a combination of strategic vision, operational proximity, and business pragmatism, enabling organizations to make decisions that are both ambitious and executable.
Core strengths
- Strategic clarity grounded in real operational understanding
- Actionable, results-driven proposals that accelerate decision-making
- Skilled negotiation across partners, customers, and suppliers in complex, high-stakes contexts
Scientist Perspective
Cristina Ochoa
Principal Consultant
PhD in Organic Chemistry with large experience in pharmaceutical industry as technology transfer, industrialization and lifecycle management for sterile products and oral dosage forms. Skilled at leading cross-functional teams including, when necessary, external stakeholders (partners, suppliers and CMOs) to deliver manufacturing scale-up, process validation and product launches under GMP. Experienced supporting CMC documentation for FDA, EMA and RoW submissions.
Highlights
- 25+ years in pharmaceutical development and CMC science
- Expertise in Tech Transfer activities with CMOs/CDMOs
- Experience in licensing/supply alliances
- Hands-on experience with FDA and EMA submissions
Why It Matters
CMC Compliance Is the License to Operate
The documented, defensible link between scientific knowledge and industrial execution — protecting patients, approvals, supply and revenue.
Regulatory Confidence
Avoid deficiencies, CRLs and inspection findings — with the dossier and manufacturing reality always aligned.
Lower Execution Risk
The right CMO/CDMO and controlled transfers, with fewer deviations, OOS results and validation failures.
Supply Protection
Proactive risk and performance oversight that prevents disruption and protects launches and revenue.
Faster, Predictable Change
Post-approval changes, scale-up and site transfers managed efficiently through the right regulatory path.
Executive value: fewer surprises, faster decisions and stronger control over external manufacturing risk.
How We Work
Flexible Engagement Models
Support can be structured around strategy, execution, independent assessment or ongoing oversight.
Strategic Advisory
Executive-level support for outsourcing strategy and CMC risk decisions.
Project-Based Support
Dedicated support for CMO selection, tech transfer or lifecycle management projects.
Independent Assessment
Gap assessments, due diligence, readiness reviews and risk evaluations.
Ongoing Oversight
Periodic CMO performance review, change control support and lifecycle monitoring.
Typical deliverables: pre-selection of candidates, due diligence reports, transfer plans, gap assessments, CMC impact assessments.
Contact
Let's De-Risk Your Next Outsourced Manufacturing Decision
From CMO/CDMO selection to tech transfer and lifecycle management, Binding Partners helps ensure that every step is controlled, compliant and aligned with long-term product success.
Contact us to discuss your outsourced API & FDF manufacturing strategy.